Foundation stone laid for Laboratoire Unither Amiens new building PRESS RELEASE Foundation stone laid for Laboratoire Unither Amiens new building As part of the Foundation Stone Laying Ceremony... View Article
Pharnext moves production of its pending drug PXT303 to the United States Published on 01/26/2023 (AOF) – Pharnext, a biotech company developing new treatments for neurodegenerative diseases without satisfactory therapeutic solutions, today... View Article
Unither Pharmaceuticals has completed the purchase of the Novartis site located at Butantã, in São Paulo, Brazil. Unither Pharmaceuticals has completed the purchase of the Novartis site located at Butantã, in São Paulo, Brazil. Paris (France), 11/28/2022... View Article
Jean-François Hilaire: newly appointed CEO of Unither Pharmaceuticals Paris (France), November 14, 2022 – Unither Pharmaceuticals’ Supervisory Board appoints Jean-François Hilaire as Chief Executive Officer. As Executive Chairman,... View Article
The Management led by Eric Goupil gathers a consortium to acquire Unither Pharmaceuticals from Ardian The Management led by Eric Goupil gathers a consortium to acquire Unither Pharmaceuticals from Ardian Wednesday, 26 October 2022 The... View Article
Mouthwash stick-packs Mouthwash stick-packs for Shenzhen Daphne (China) We developed and manufactured Mouthwash stick-packs in collaboration thanks to our Colomiers and Wuhan... View Article
Laboratoire Unither Coutances inaugurates its new premises and production facilities Coutances (France), September 21, 2022 – Laboratoire Unither Coutances has opened its new production facilities and workshops, acquiring the world’s... View Article
Official launch of the CURECALL solution to ophthalmologists in France! L’aventure CURECALL vient de franchir une nouvelle étape avec le lancement officiel de la solution dédiée aux ophtalmologues libéraux en... View Article
New in corneal transplant rejection: the ANSM issues an authorisation for the first industrial eye drop based on ciclosporin 2%. New in corneal transplant rejection: the ANSM issues an authorisation for the first industrial eye drop based on ciclosporin 2%.... View Article
